NRL972_IVCO

A randomised, open, controlled crossover study in male and female healthy volunteers to describe the plasma pharmacokinetics of cholyl-lysyl-fluorescein (NRL972) during and after a constant rate 2 hour iv-infusion of 5 and 15 mg NRL972 per hour.